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Introduction 
The Mendelsohn Maneuver, or voluntary prolongation of hyolaryngeal elevation at the peak 
of the swallow, has been used to treat patients with pharyngeal dysphagia for many 
years1–3--sometimes as a compensatory strategy to help the bolus pass more efficiently 
through the pharynx4–6 and sometimes as part of a rehabilitative exercise program7–10. Early 
reports on the Mendelsohn maneuver suggested use of the maneuver increases laryngeal 
elevation and maximal hyoid superior displacement and provides an immediate effect in 
prolonging the duration of opening of the upper esophageal sphincter (UES) but not the 
diameter1–6. Since the initial reports, more data have emerged supporting the physiologic 
effects of the Mendelsohn maneuver on the act of swallowing, but most papers consider only 
the immediate effects of the maneuver on small numbers of normal participants or patients11–
14. 
Rehabilitation, like compensation, addresses deficits in swallowing physiology15, but rather 
than providing an immediate change in the physiology of swallowing, an exercise designed 
to rehabilitate should provide a lasting effect on swallowing. A few studies provide outcome 
data on patients with dysphagia who have used the Mendelsohn maneuver as part of a 
collection of exercises with the goal of rehabilitation, but none have used the maneuver in 
isolation and reported on change in swallowing physiology as a result7–9. While use of the 
maneuver shows promise when included as part of a broader regimen of treatment, the 
specific physiologic effects of the Mendelsohn maneuver on patients with dysphagia cannot 
be determined without investigation of the maneuver in isolation. The studies reporting 
positive outcomes incorporating the maneuver also employed techniques, such as head turns, 
chin tucks, supraglottic swallows, effortful swallows, and the Shaker exercise, amongst 
others. Moreover, while outcome data from these studies reported improved oral intake in 
most patients without development of pneumonia or other negative health consequences, 
specific changes in swallow physiology were not reported, leaving open questions regarding 
the functional and physiologic changes which may have occurred, as well as the actual cause 
of those changes (i.e., time, swallowing food and liquid, doing exercises—and which 
exercises). These studies have clearly demonstrated that dysphagia rehabilitation is possible 
in certain patients post-stroke; but without specifically examining the use of individual 
exercises in isolation, the contribution of any particular exercise cannot be clearly defined. 
In other words, while the Mendelsohn maneuver appears to have an immediate effect on 
hyolaryngeal movement and duration of UES opening, no data exist to define what, if any, 
lasting effect use of the Mendelsohn maneuver over time may have on the physiology of 
swallowing when the Mendelsohn maneuver is no longer employed. 
Based on the reports regarding the immediate effects of the Mendelsohn maneuver on 
swallowing, we would anticipate that if long term changes result from use of the 
Mendelsohn as an exercise, they would include duration of hyolaryngeal elevation, 
anteriorly an/or superiorly, and, consequently, duration of opening of the upper esophageal 
sphincter.1–6 When swallowing, the hyoid bone and thyroid cartilage begin to rise, then the 
hyoid bone begins to move superiorly and anteriorly in a quick burst of movement. The path 
of this movement can vary but is often triangular, moving superiorly, then anteriorly and 
then back to rest or vice-versa (anteriorly, then superiorly, then back to rest). These 
durations can be measured as “duration of hyoid maximum anterior excursion” (DOHMAE) 
and “duration of hyoid maximum elevation” (DOHME)16. These do not measure the 
duration of hyoid movement from start to finish but rather the duration that the hyoid 
remains at it’s maximum anterior and superior points. Duration of hyoid movement from 
start to finish is measured as “pharyngeal response duration” (PRD). Movement of the 
hyoid, especially the anterior movement, should create a traction pull on the cricoid cartilage 
which allows for prolonged opening of the UES2, which can be measured as “duration of 
UES opening” (DOUESO)16. 
The purpose of this investigation was to determine if any lasting changes would occur in 
swallowing physiology as a result of intensive exercise using the Mendelsohn maneuver. 
Our hypothesis was that measures of the duration of hyoid movement and the duration of 
UES opening would significantly improve. We also hypothesized that measures of bolus 
flow—penetration/aspiration and pharyngeal residue—would improve as a result of these 
changes. In addition, we wanted to obtain some preliminary information regarding dose- 
response, which could be examined by comparing results after 10 sessions and 20 sessions 
of treatment. Other measures of oral and pharyngeal swallowing duration were analyzed, as 
well as outcomes on the Dysphagia Outcome and Severity Scale17. 
METHODS 
Participants 
Participants were recruited through advertising and referrals at The University of Arkansas 
for Medical Sciences Medical Center, as well as word of mouth via area speech-language 
pathologists. All participants provided written consent and all procedures were approved by 
the hospital’s Institutional Review Board. 
Eighteen individuals, age 21 and older, who suffered a stroke and were dysphagic 
participated in this investigation (see Table 1). Each was between six weeks and 22 months 
post stroke (9.5 months average) at the time of participation. Based on limited data in the 
literature and numerous potential impacts on pharyngeal swallowing, we chose to broadly 
enroll patients who were post-stroke for this pilot study. Patients who had pharyngeal 
dysphagia characterized by any apparent reductions in hyolaryngeal elevation and or UES 
opening and evidence of some type of residue in the pharynx were invited to participate. 
These were visual judgments made by the principal investigator during the initial VFSS. 
Each participant also had to be on a restricted diet, defined by need for a nasogastric, 
jejunostomy, or percutaneous endoscopic gastrostomy tube, or an oral diet that was altered 
in any way due to swallowing difficulty. Individuals with an absent swallow were not 
included in the study. All individuals had to demonstrate at least a minimal functional 
swallow with some material passing through the UES. Aspiration was not required for 
participation. 
All participants scored 75 or higher on the Modified Mini-Mental State Examination. 
Individuals with current/history of tracheotomy or other structural alteration to the 
swallowing mechanism, history of swallowing problems prior to the stroke, progressive 
neurologic disease, or cognitive and/or physical problems which would have impeded 
understanding or completion of the therapeutic tasks were excluded. A history questionnaire 
and a cranial nerve/oral motor screen helped determine the exact nature of the stroke and 
further define overall impairment. MRIs or CT Scans were obtained when available. In the 
absence of neuroimaging information, a neurological examination was performed by the 
study physician. 
Each participant underwent an initial VFSS to ensure physiologic fit with the study as well 
as a baseline of swallowing function. If swallowing function appeared to be normal or did 
not meet the above inclusion criteria related to swallow physiology the participant was 
withdrawn from the study. Each remaining individual was randomized, via pre-study 
blinded number drawing, into one of two groups: Group A received two weeks of treatment 
followed by two weeks of no-treatment (BBAA) and Group B received two weeks of no 
treatment followed by two weeks of treatment (AABB). VFSSs were conducted at the end of 
each week of the study (A or B) to allow for dose-response comparisons of baseline 
measures of swallowing with measures at 1 and 2 weeks post treatment and no-treatment. 
Measures 
Videofluoroscopic Swallowing Studies (VFSS)—Eighteen participants were 
recruited to participate in this study over nearly five years. Even though the overall duration 
of the study was protracted and some methods of data acquisition varied between subjects, 
they were kept constant for each participant as to not impact pre- and post-measures. The 
majority of VFSSs (N=13) were conducted using a Shimadzu Corporation (Columbia, MD) 
Digital Fluoroscope (Model F100-02) and were transferred to a KAY Elemetrics Swallow 
Station (now KAY/PENTAX, Montvale, NJ). Due to the logistics of a hospital renovation 
and a few subjects being evaluated at another local hospital, 5 studies were recorded directly 
onto a Sony S-VHS through a FOR-A (Fort Lee, NJ) 100 millisecond videotimer (model 
VTG 33). Data from the KAY swallow station were also transferred to a JVC (Wayne, NJ) 
SVHS/DVD player (model SR-MV40) through the videotimer. No loss of imaging occurred 
during the transfer. This method helped ensure blinded review of studies. All recordings 
were 30 frames per second but were analyzed to the 100th of a second using the videotimer. 
Participants swallowed three 3 mL thin liquids (E-Z-HD Barium sulfate powder for 
suspension and water/50-50; approximately 14 centipoise) and three 3 mL purees (3 parts 
applesauce to 1 part barium powder) for each study. The studies were brief (6 swallows with 
less than 1 minute fluoro) in comparison to typical clinical studies (12–15 swallows and 4–5 
minutes fluoro) to limit radiation exposure. All swallows were viewed in the lateral plane 
with a view of the oropharyngeal area—including the hard palate superiorly, the 
cricopharyngeal area inferiorly, the lips anteriorly, and the posterior pharyngeal wall 
posteriorly. Patients were instructed to hold the bolus until they were asked to swallow and 
to use subsequent swallows, if needed, to clear the bolus. 
Duration measures, analyzed using the JVC SVHS/DVD player (model SR-MV40) with 
frame by frame viewing, are defined in Table 2. Our primary measures (DOHME, 
DOHMAE, and DOUESO) were movement durations for specific structures, as was 
pharyngeal response duration (PRD), which is the total duration on hyoid movement. 
Duration measures representing bolus flow (i.e., OTD, PTD, TSD) were also rated. In 
addition to measures of swallowing duration, each swallow was rated on an 8-point 
penetration-aspiration scale18–19, a scale of oropharyngeal residue (0 = none, 1 = trace 
coating, 2 = pooling)20, and the DOSS17. The 8-point penetration-aspiration (P/A) scale 
rates P/A on the depth of the misdirected bolus into the airway (i.e., above, on, or below the 
vocal folds) and the participant’s response to it (i.e., coughed but did not clear, coughed and 
cleared, no cough). A rating of 1 is no P/A, 5 is penetration to the vocal folds, and 6 and 
greater are aspiration events. The DOSS is a seven point scale where 7 indicates normal 
swallowing and 1 and 2 indicate severe dysphagia where nothing is allowed by mouth or 
only therapeutic feedings. Scores in the 3–5 range indicate mild to moderate impairment 
where diets are adjusted and compensatory strategies are used. 
The PI was the primary person responsible for data analysis. All measures for data analysis 
were rated from tapes and DVDs by the PI and not at the time of the study. All SVHS tapes 
and DVDs were labeled with numbers corresponding to participants. In reviewing individual 
tapes there was no way to know whether ratings were being made for swallow studies after 
periods of treatment or no-treatment as no marks identifying the order for each participant 
were present. 
Treatment Sessions—During treatment weeks (B weeks), participants were seen twice a 
day for sessions lasting between 45 minutes and one hour with a 2–3 hour break in between 
sessions depending on participants’ schedules and availability. Each participant was taught 
the Mendelsohn maneuver, the process of squeezing and holding the larynx at the peak of 
the swallow, using surface electromyography (SEMG) biofeedback. SEMG biofeedback was 
provided via a two channel Pathway MR-20 (Prometheus Group, Dover, NH). The electrode 
pad was placed submentally at midline halfway between the mental symphysis and the tip of 
the hyoid bone. Ground and active electrodes are linear on the pad and are not adjustable. 
The signal derived from muscle activity was rectified and low pass filtered to produce a 
smooth signal. SEMG tracings were used only for participant biofeedback. Treatment 
sessions were administered primarily by the PI with some assistance from a study clinician 
once participants were well-trained with the treatment protocol. 
Session 1 focused on defining and demonstrating the procedure, as well as teaching the 
patient to do the maneuver correctly. The PI demonstrated the maneuver and provided visual 
feedback from the computer as well as tactile feedback via laryngeal palpation (the 
participant feeling the rise, squeeze, and fall of the PIs larynx). In cases where it was more 
difficult to determine whether swallows were actually occurring, cervical auscultation was 
employed along with laryngeal palpation for auditory and tactile confirmation. Prior to each 
swallow, dental swabs were dipped in ice water and delivered to the mouth to provide a 
small amount of water. It was not our intent to provide a bolus swallow but simply to 
moisten the mouth so swallowing would be possible throughout the session. After observing 
the PI, the participant attempted to replicate the clinician’s swallow, palpating his own 
larynx and watching the SEMG tracing on the computer screen. 
Coaching and correcting continued with sessions 2, 3, and, to some extent, throughout the 
study. Beginning with session 2 on the first day, each participant began the standard regimen 
of treatment of 30 to 40 swallows per session utilizing the Mendelsohn maneuver. 
Participants were first baselined—meaning they were asked to swallow hard without looking 
at the computer. An SEMG target line for amplitude was then set at 5 microvolts above their 
mean established from three baseline swallows. This was simply to ensure the swallows 
were made with sufficient strength to recruit muscles. The clinician then asked the 
participant to face the screen and instructed the participant to swallow “long and strong” 
with a squeeze at the peak of the swallow for 3 to 4 seconds. The dental swab was delivered 
to the participant’s mouth by the clinician and the participant watched the video monitor and 
performed the maneuver. The clinician froze the video frame after each swallow and 
provided visual and verbal feedback regarding the strength (amplitude) and duration 
(seconds) of the swallow. Specifically, the following were pointed out to the participant: 1) 
the onset and offset points and the duration of the swallow—including the initial rise of the 
SEMG tracing, which should appear similar to a straight back chair; 2) the peak amplitude, 
as provided by the Prometheus software; 3) the duration of the current swallow as compared 
to the previous swallow. 
Forty swallows per session were targeted, but participants were allowed to stop at a 
minimum of 30 if they showed signs of uncomfortable fatigue. At least 30 Mendelsohn 
swallows were completed during each treatment session. A successful Mendelsohn swallow 
meant the participant was able to swallow and sustain laryngeal elevation for approximately 
2 seconds or greater. Using SEMG for biofeedback, all participants were able to swallow 
and sustain some semblance of laryngeal elevation for approximately 2 seconds throughout 
treatment. 
Data Analysis 
VFSS data were gathered across five points, including an initial study and four more which 
occurred after each week of enrollment, treatment or no-treatment. Our primary comparison 
was between ratings of DOHME, DOHMAE, and DOUESO after two weeks of treatment 
and two weeks of no-treatment, though comparisons were made after 1 week and 3 weeks to 
consider dose-response. Due to the small size of our sample, we did not have enough power 
to perform a repeated measures analysis of variance. As our objectives were exploratory in 
nature, we treated the data points as independent measures and utilized T-tests for 
independent groups (A versus B). A Bonferroni adjustment was used for stricter control of 
family wise error rate moving the acceptable p value from .05 to .017. All other data— 
additional duration measures, residue on a 3 point scale, penetration/aspiration on an 8 point 
scale, and swallowing severity on the DOSS 7-point scale are provided descriptively. 
Intrajudge reliability was derived by having the PI re-analyze a random selection of 10% of 
all VFSS measures. Interjudge reliability was derived by having a second clinician analyze a 
random selection of 10% of VFSS measures. The second clinician was a certified speech- 
language pathologists with at least 100 hours of experience with VFSS, and was trained to 
criterion prior to the initiation of the study. Some interjudge reliability ratings were made 
without blinding to name, but the reliability clinician was never aware of treatment 
condition. All measures of reliability were analyzed using intraclass correlation coefficients 
(ICC). 
Interjudge reliability was high for all measures. ICCs for the primary measures were as 
follows: DOHME = .749, p = .000; DOHMAE = .775, p = .000; DOUESO = .649, p = .002. 
Intrajudge reliability as follows: DOHME = .787, p = .000; DOHMAE = .842, p = .000; 
DOUESO = .689, p = .002. Intra- and interjudge reliability for all other measures was 
significant with ICCs ranging from a low of .556 (p = .000) for OTD to a high of .998 (p = . 
000) for PTD. 
RESULTS 
Table 3 provides results for the primary outcome measures of DOHME, DOHMAE, and 
DOUESO. 
Pre-treatment mean durations are compared with mean durations after one week of 
treatment, two weeks of treatment, one week of no-treatment and two weeks of no- 
treatment. Bear in mind that treatment weeks did not always occur after no-treatment weeks. 
In roughly half the cases, no-treatment periods occurred after treatment periods and could, 
therefore, have been influenced by the prior two weeks of treatment. Results indicate all 
duration measures improved (increased) during treatment weeks and worsened (decreased) 
during no treatment weeks. Results after two weeks of treatment were better than results 
after one week of treatment, and results after two weeks of no-treatment were worse than 
results after one week of no-treatment with the exception of DOUESO, which made a non- 
significant improvement in respective no-treatment weeks. Improvements in DOHME and 
DOHMAE were significant (p = .011 and .009 respectively) at two weeks post-treatment. 
No other results were significant. Results for these measures are also presented in Figure 1. 
Table 4 provides means for all other measures at study initiation, post two weeks of no- 
treatment, and post two weeks of treatment. Results for pharyngeal response duration 
(PRD), which measures the duration of hyoid movement from start to finish, trended with 
DOHME and DOHMAE, getting worse during periods of no-treatment and better during 
periods of treatment. No other measures trended this direction. Differences between 
treatment and no-treatment weeks were minimal, at best, for stage transition duration 1 
(head of bolus), stage transition duration 2 (first barium in pharynx), pharyngeal transit 
duration, penetration/aspiration, vallecular residue, pyriform residue, and dysphagia severity 
(DOSS) ratings. 
DISCUSSION 
“The fundamental purpose of Phase I research is selecting a therapeutic effect, identifying it 
if present, and estimating its magnitude”21. While the Mendelsohn maneuver is not new, no 
prior research has sought to determine the therapeutic effects of the maneuver when 
administered as an exercise in isolation to patients. Compensatory, or immediate, effects are 
only useful in as much as a maneuver, or strategy, is employed. Data on normal participants 
and case studies performing the Mendelsohn maneuver in isolation during bolus 
swallows 1–6 has shown improved hyolaryngeal movement and UES opening. For the 
current investigation, we hypothesized that duration of superior and anterior maximal hyoid 
movement would be prolonged, as well as duration of UES opening. In fact, this was the 
case. Data show that DOHME (hyoid elevation) and DOHMAE (hyoid anterior excursion) 
significantly improved (were prolonged) during VFSS evaluation of swallowing after 
treatment weeks and did not improve after no-treatment weeks. Research has previously 
reported that the duration of hyoid movement anteriorly and superiorly is reduced post- 
stroke compared to normals22. Such reductions could affect other aspects of swallowing, 
including duration of UES opening and bolus flow. Duration of upper esophageal sphincter 
opening (DOUESO) also improved during treatment weeks compared to no-treatment 
weeks, though results were not statistically significant. With a larger sample, it is very 
possible this trend would continue and become significant. 
We also sought to provide initial data regarding dose-response. VFSSs were performed after 
each week of enrollment, treatment or no-treatment. Data clearly suggest that while 
improvement was made in all three measures after 10 sessions of treatment, effects were 
much greater after 20 sessions. It is very possible that continuing use of the exercise over 
time, possibly with treatment sessions spread out for cycles of work and rest, would 
continue to enhance therapeutic effects and provide greater impact on additional measures of 
swallowing function, including DOUESO. Prior studies employing the Mendelsohn 
maneuver have reported success with sessions once or twice daily over a 1 to 2 week period 
providing intense neuromuscular rehabilitation in an effort to improve both the strength and 
coordination of the swallow7–9. Part of the rationale for this regiment of treatment lies in the 
concept that swallowing post-stroke can become not only weak but discoordinated9, and 
more coordinated “patterns” of swallowing activity occur with more intensive treatment. 
Pure strength training, on the other hand, may benefit not only from “overload” but also 
periods of rest scheduled over a longer period of time23. At the time this study was initiated, 
the investigators chose the more intensive approach as outlined in the related studies, but 
future research should examine different treatment regimens of duration and intensity. 
Effects on Other Measures of Swallowing 
As Table 4 indicates, few other measures were affected by exercise with the Mendelsohn 
maneuver in this study. These results are not terribly surprising, however. Dysphagia is a 
complex disorder and we did not expect to find major reductions in dysphagia severity with 
two weeks of one type of exercise. Pharyngeal response duration trended the way of 
DOHME and DOHMAE. This makes perfect sense in that all three are different measures of 
the duration of hyoid movement. We hypothesized the hyoid would be affected by this 
exercise, and this was the case. Measures of bolus flow, however, may be affected by factors 
other than hyoid movement—i.e., pharyngeal muscle strength, epiglottic tilt and seal, or 
tongue base strength. 
With improvements in the duration of UES opening, pyriform sinus residue should logically 
improve more than it did in this study. Our broad inclusion criteria allowed us to consider 
many possible effects of the maneuver on swallowing physiology but likely impacted this 
measure. Had more participants demonstrated moderate to severe pyriform residue, then 
results for this rating may have improved more substantially. Likewise, penetration/ 
aspiration might have improved more if only individuals with post-swallow aspiration from 
the pyriform sinuses had been included. The current results indicating improvements in 
duration of hyoid movements and UES opening lend support to future studies with more 
specific focus on bolus flow in the form of pyriform sinus residue and post-swallow 
aspiration. Such studies should include larger numbers of participants and examine different 
intensities of treatment over varying durations of time. Additionally, the effects of the 
exercise on swallowing physiology should be examined over longer periods of time than one 
month. Outcome measures at 6 and 12 months should be examined. 
Study Limitations 
Our results are derived from a small sample of stroke patients. Our primary measures 
improved in the direction we hypothesized but only 2 of the 3 reached a level of 
significance. Larger numbers are needed in future investigations, as are variations in 
treatment regimens, duration, and intensity. Also, we wanted to examine the “post-acute 
rehabilitation but not necessarily chronic population,” but individuals who met the specific 
criteria and were willing and able to participate were limited. Data collection took twice as 
long as expected and participants were enrolled up to nearly two years post-stroke. Some of 
these could easily be classified as chronic. Comparing results of individuals less than one 
year post-stroke to those two years and beyond would provide valuable information 
regarding the recovery potential at different points in the rehabilitation process. 
CONCLUSION 
Our exploratory study indicates the Mendelsohn maneuver, used as a rehabilitation exercise, 
can improve the duration of hyoid maximum anterior and superior movement and impact the 
duration of UES opening. These results are consistent with reports on use of the maneuver 
as a compensatory strategy but present the maneuver as an option for longer lasting changes 
in the target areas of swallowing physiology. With longer enrollment in treatment and, 
perhaps, combined with other treatments, it can potentially improve bolus flow and 
dysphagia severity. More research is needed. Additional measures of biomechanical 
movements—such as the extent of hyolaryngeal movement and UES opening—are currently 
being analyzed. 
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Figure 1. 
Graph of primary duration measures after two weeks of no treatment versus two weeks of 
treatment. DOUESO = Duration of opening of the upper esophageal sphincter. DOHMAE = 
Duration of hyoid maximum anterior excursion. DOHME = Duration of hyoid maximum 
elevation. 
Participant demographics. 
Table 1 
Participant Age Gender Site of Lesion Months Post 
1 70 M L Medulla 18 
2 42 M R Brainstem 15 
3 69 M IC SAH 16 
4 58 F L SAH 22 
5 57 F L Brainstem 12 
6 88 M B White Matter 8 
7 61 M L Brainstem 2 
8 84 F Nonspecified 1.5 
9 73 M R Frontal Lobe 2 
10 86 F R Corona Radiata 3 
11 55 F Left IC/Pons 8 
12 70 F R Medulla 12 
13 54 F Nonspecified 6 
14 73 M Nonspecified 18 
15 66 M L Basal Ganglia 9 
16 88 M R Brainstem 15 
17 86 M R Brainstem 2 
18 83 M R Temporal & Insula 4 
L = left; R = right; B = bilateral; IC = internal capsule; SAH = subarachnoid hemorrhage; 
Oropharyngeal Duration Measures 
Table 2 
Abbre-Measure viation Description of Measure 
DOHME 
DOHMAE 
Duration of hyoid maximum elevation 
Duration of hyoid max anter excursion 
PRIMARY MEASURES 
From hyoid first maximum elevation to hyoid last maximum elevation. 
From first frame showing maximum anterior hyoid movement to last frame showing 
maximum anterior hyoid movement. 
DOOUES Duration of UES Open From the time UES opens to the time UES closes 
OTHER MEASURES ANALYZED 
OTD Oral transit duration Beginning of posterior movement of the bolus to the bolus head at ramus of mandible. 
PTD Pharyngeal transit duration From bolus head at ramus of mandible to bolus head entering cricopharyngeus. 
TSD Total swallow duration Beginning of posterior movement of the bolus to hyoid return to rest 
STD 1 Stage transition duration From bolus head at ramus of mandible to initiation of maximal hyoid excursion. 
STD 2 Stage transition duration 2 From first barium at ramus of mandible to initiation of maximal hyoid excursion. 
PRD Pharyngeal response duration From initiation of maximum hyoid excursion to hyoid return to rest. 
DTOUES Duration to open UES From beginning of posterior bolus movement to UES opening. 
Table 3 
Primary duration measures at 1 and 2 weeks post-treatment and 1 and 2 weeks post-no treatment compared with pre-treatment. t value, degrees of 
freedom, & significance for each week. 
Duration Measure Mean Pre-Treatment Mean 1 Week Treatment Mean 2 Weeks Treatment Mean 1 Week No Treatment Mean 2 Weeks No Treatment 
DOHME .213 .196 t(192)=.808 .233 t(142)=−.108 .212 t(189)=−1.12 .210 t(180)=−.6684 
p = .952 p = .011 p = .918 p = .242 
DOHMAE .222 .223 t(188)=−.072 .250 t(148)=−.543 .227 t(183)=−.568 .220 t(174)=.115 
p = .507 p = .009 p = .668 p = .172 
DOUESO .592 .606 t(177)=−.607 .614 t(159)=−1.150 .581 t(179)=.578 .589 t(177)=−.724 
p = .351 p=.472 p = .236 p=.550 
DOHME – Duration of Hyoid Maximum Elevation; DOHMAE – Duration of Hyoid Maximum Anterior Excursion; DOOUES – Duration of Upper Esophageal Sphincter Opening. 
Table 4 
Means for all other measures at study initiation and after 2 weeks of treatment and 2 weeks of no-treatment. 
Measure Mean Study Initiation Mean Post No-Treatment Mean Post Treatment 
Oral Transit .569 .693 .604 
Stage Transition 1 .843 .706 .734 
Stage Transition 2 .826 .587 .642 
Pharyngeal Transit .987 .763 .887 
Pharyngeal Response .895 .833 .911 
To UES Open 1.88 1.47 1.41 
Penetration/Aspiration 3.13 2.30 2.99 
Vallecular Residue 1.21 .83 1.10 
Pyriform Residue .90 .65 .73 
DOSS 3.92 4.61 4.49 
UES = Upper esophageal Sphincter; DOSS = Dysphagia Outcome Severity Scale 
Pharyngeal Response Duration trended with primary measures of DOHME and DOHMAE. 
